Prostaglandin E 2 affects T cell responses through modulation of CD46 expression

Journal of Immunology

Volumn 188, Issue 11, 2012, Pages 5303-5310

  Kickler, Karoline ^a   Maltby, Kathryn ^a   Choileain, Siobhán Ni ^a   Stephen, Jillian ^a   Wright, Sheila ^a   Hafler, David A ^b,c   Jabbour, Henry N ^a   Astier, Anne L ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; MEMBRANE COFACTOR PROTEIN; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROSTANOID; CD46 PROTEIN, HUMAN; GRK1 PROTEIN, HUMAN; RHODOPSIN KINASE;

ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; RECEPTOR BINDING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD46; CELL PROLIFERATION; CELLS, CULTURED; DINOPROSTONE; G-PROTEIN-COUPLED RECEPTOR KINASE 1; GENE EXPRESSION REGULATION; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; RNA INTERFERENCE; T-LYMPHOCYTE SUBSETS;

EID: 84862093139     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103090     Document Type: Article

References (63)

1. Seya, T., J. R. Turner, and J. P. Atkinson. 1986. Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b. J. Exp. Med. 163: 837-855. (Pubitemid 16082802)
2. Lublin, D. M., M. K. Liszewski, T. W. Post, M. A. Arce, M. M. Le Beau, M. B. Rebentisch, L. S. Lemons, T. Seya, and J. P. Atkinson. 1988. Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins. J. Exp. Med. 168: 181-194.
3. Astier, A., M. C. Trescol-Biémont, O. Azocar, B. Lamouille, and C. Rabourdin-Combe. 2000. Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J. Immunol. 164: 6091-6095. (Pubitemid 30408783)
4. Zaffran, Y., O. Destaing, A. Roux, S. Ory, T. Nheu, P. Jurdic, C. Rabourdin- Combe, and A. L. Astier. 2001. CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J. Immunol. 167: 6780-6785. (Pubitemid 33144168)
5. Oliaro, J., A. Pasam, N. J. Waterhouse, K. A. Browne, M. J. Ludford-Menting, J. A. Trapani, and S. M. Russell. 2006. Ligation of the cell surface receptor, CD46, alters T cell polarity and response to antigen presentation. Proc. Natl. Acad. Sci. USA 103: 18685-18690. (Pubitemid 44913471)
6. Kemper, C., A. C. Chan, J. M. Green, K. A. Brett, K. M. Murphy, and J. P. Atkinson. 2003. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421: 388-392. (Pubitemid 36157938)
7. Grossman, W. J., J. W. Verbsky, B. L. Tollefsen, C. Kemper, J. P. Atkinson, and T. J. Ley. 2004. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104: 2840-2848. (Pubitemid 39434970)
8. Cardone, J., G. Le Friec, P. Vantourout, A. Roberts, A. Fuchs, I. Jackson, T. Suddason, G. Lord, J. P. Atkinson, A. Cope, et al. 2010. Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells. Nat. Immunol. 11: 862-871.
9. Cole, D. S., T. R. Hughes, P. Gasque, and B. P. Morgan. 2006. Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis. Mol. Immunol. 43: 1953-1964.
10. Hakulinen, J., and J. Keski-Oja. 2006. ADAM10-mediated release of complement membrane cofactor protein during apoptosis of epithelial cells. J. Biol. Chem. 281: 21369-21376. (Pubitemid 44115476)
11. Ni Choileain, S., N. J. Weyand, C. Neumann, J. Thomas, M. So, and A. L. Astier. 2011. The dynamic processing of CD46 intracellular domains provides a molecular rheostat for T cell activation. PLoS ONE 6: e16287.
12. Weyand, N. J., C. M. Calton, D. L. Higashi, K. J. Kanack, and M. So. 2010. Presenilin/gamma-secretase cleaves CD46 in response to Neisseria infection. J. Immunol. 184: 694-701.
13. Astier, A. L., and D. A. Hafler. 2007. Abnormal Tr1 differentiation in multiple sclerosis. J. Neuroimmunol. 191: 70-78. (Pubitemid 350061001)
14. Astier, A. L., G. Meiffren, S. Freeman, and D. A. Hafler. 2006. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J. Clin. Invest. 116: 3252-3257. (Pubitemid 44878639)
15. Martinez-Forero, I., R. Garcia-Munoz, S. Martinez-Pasamar, S. Inoges, A. Lopez-Diaz de Cerio, R. Palacios, J. Sepulcre, B. Moreno, Z. Gonzalez, B. Fernandez-Diez, et al. 2008. IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis. Eur. J. Immunol. 38: 576-586.
16. Ma, A., Z. Xiong, Y. Hu, S. Qi, L. Song, H. Dun, L. Zhang, D. Lou, P. Yang, Z. Zhao, et al. 2009. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys. Int. Immunopharmacol. 9: 599-608.
17. Xu, Y. Q., Y. D. Gao, J. Yang, and W. Guo. 2010. A defect of CD4+CD25+ regulatory T cells in inducing interleukin-10 production from CD4+ T cells under CD46 costimulation in asthma patients. J. Asthma 47: 367-373.
18. Astier, A. L., G. Beriou, T. M. Eisenhaure, S. M. Anderton, D. A. Hafler, and N. Hacohen. 2010. RNA interference screen in primary human T cells reveals FLT3 as a modulator of IL-10 levels. J. Immunol. 184: 685-693.
19. Moore, C. A., S. K. Milano, and J. L. Benovic. 2007. Regulation of receptor trafficking by GRKs and arrestins. Annu. Rev. Physiol. 69: 451-482. (Pubitemid 46457651)
20. Aragay, A. M., A. Ruiz-Gómez, P. Penela, S. Sarnago, A. Elorza, M. C. Jiménez-Sainz, and F. Mayor, Jr. 1998. G protein-coupled receptor kinase 2 (GRK2): mechanisms of regulation and physiological functions. FEBS Lett. 430: 37-40. (Pubitemid 28307027)
21. Pitcher, J. A., N. J. Freedman, and R. J. Lefkowitz. 1998. G protein-coupled receptor kinases. Annu. Rev. Biochem. 67: 653-692. (Pubitemid 28411141)
22. Ribas, C., P. Penela, C. Murga, A. Salcedo, C. García-Hoz, M. Jurado-Pueyo, I. Aymerich, and F. Mayor, Jr. 2007. The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim. Biophys. Acta 1768: 913-922. (Pubitemid 46452540)
23. Vroon, A., C. J. Heijnen, and A. Kavelaars. 2006. GRKs and arrestins: regulators of migration and inflammation. J. Leukoc. Biol. 80: 1214-1221. (Pubitemid 44904958)
24. Neuschäfer-Rube, F., M. Oppermann, U. Möller, U. Böer, and G. P. Püschel. 1999. Agonist-induced phosphorylation by G protein-coupled receptor kinases of the EP4 receptor carboxyl-terminal domain in an EP3/EP4 prostaglandin E(2) receptor hybrid. Mol. Pharmacol. 56: 419-428.
25. Harris, S. G., J. Padilla, L. Koumas, D. Ray, and R. P. Phipps. 2002. Prostaglandins as modulators of immunity. Trends Immunol. 23: 144-150. (Pubitemid 34178297)
26. Demeure, C. E., L. P. Yang, C. Desjardins, P. Raynauld, and G. Delespesse. 1997. Prostaglandin E2 primes naive T cells for the production of antiinflammatory cytokines. Eur. J. Immunol. 27: 3526-3531. (Pubitemid 28018052)
27. Benbernou, N., S. Esnault, H. C. Shin, H. Fekkar, and M. Guenounou. 1997. Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology 91: 361-368. (Pubitemid 27304271)
28. Yao, C., D. Sakata, Y. Esaki, Y. Li, T. Matsuoka, K. Kuroiwa, Y. Sugimoto, and S. Narumiya. 2009. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat. Med. 15: 633-640.
29. Esaki, Y., Y. Li, D. Sakata, C. Yao, E. Segi-Nishida, T. Matsuoka, K. Fukuda, and S. Narumiya. 2010. Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 107: 12233-12238.
30. Tatara, R., K. Ozaki, Y. Kikuchi, K. Hatanaka, I. Oh, A. Meguro, H. Matsu, K. Sato, and K. Ozawa. 2011. Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation. Cytotherapy 13: 686-694.
31. Bouffi, C., C. Bony, G. Courties, C. Jorgensen, and D. Noël. 2010. IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS ONE 5: e14247.
32. Chizzolini, C., R. Chicheportiche, M. Alvarez, C. de Rham, P. Roux-Lombard, S. Ferrari-Lacraz, and J. M. Dayer. 2008. Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood 112: 3696-3703.
33. Boniface, K., K. S. Bak-Jensen, Y. Li, W. M. Blumenschein, M. J. McGeachy, T. K. McClanahan, B. S. McKenzie, R. A. Kastelein, D. J. Cua, and R. de Waal Malefyt. 2009. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J. Exp. Med. 206: 535-548.
34. Barrie, A., A. Khare, M. Henkel, Y. Zhang, M. M. Barmada, R. Duerr, and A. Ray. 2011. Prostaglandin E2 and IL-23 plus IL-1b differentially regulate the Th1/Th17 immune response of human CD161(+) CD4(+) memory T cells. Clin. Transl. Sci. 4: 268-273.
35. Sheibanie, A. F., J. H. Yen, T. Khayrullina, F. Emig, M. Zhang, R. Tuma, and D. Ganea. 2007. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23->IL-17 axis. J. Immunol. 178: 8138-8147. (Pubitemid 46898086)
36. Baratelli, F., Y. Lin, L. Zhu, S. C. Yang, N. Heuzé-Vourc'h, G. Zeng, K. Reckamp, M. Dohadwala, S. Sharma, and S. M. Dubinett. 2005. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J. Immunol. 175: 1483-1490. (Pubitemid 41023048)
37. Pillai, V., and N. J. Karandikar. 2008. Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity. Blood 111: 463-464, author reply 464-466.
38. Moffat, J., D. A. Grueneberg, X. Yang, S. Y. Kim, A. M. Kloepfer, G. Hinkle, B. Piqani, T. M. Eisenhaure, B. Luo, J. K. Grenier, et al. 2006. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124: 1283-1298.
39. Catalano, R. D., M. R. Wilson, S. C. Boddy, A. T. McKinlay, K. J. Sales, and H. N. Jabbour. 2011. Hypoxia and prostaglandin E receptor 4 signalling pathways synergise to promote endometrial adenocarcinoma cell proliferation and tumour growth. PLoS ONE 6: e19209.
40. De Blasi, A., G. Parruti, and M. Sallese. 1995. Regulation of G protein-coupled receptor kinase subtypes in activated T lymphocytes. Selective increase of beta-adrenergic receptor kinase 1 and 2. J. Clin. Invest. 95: 203-210.
41. Ramer-Quinn, D. S., R. A. Baker, and V. M. Sanders. 1997. Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J. Immunol. 159: 4857-4867. (Pubitemid 127471022)
42. Sánchez, A., M. J. Feito, and J. M. Rojo. 2004. CD46-mediated costimulation induces a Th1-biased response and enhances early TCR/CD3 signaling in human CD4+ T lymphocytes. Eur. J. Immunol. 34: 2439-2448. (Pubitemid 39302801)
43. Chun, K. S., and R. Langenbach. 2011. The prostaglandin E2 receptor, EP2, regulates survivin expression via an EGFR/STAT3 pathway in UVB-exposed mouse skin. Mol. Carcinog. 50: 439-448.
44. Cheon, H., Y. H. Rho, S. J. Choi, Y. H. Lee, G. G. Song, J. Sohn, N. H. Won, and J. D. Ji. 2006. Prostaglandin E2 augments IL-10 signaling and function. J. Immunol. 177: 1092-1100. (Pubitemid 44036612)
45. Buettner, R., M. Huang, T. Gritsko, J. Karras, S. Enkemann, T. Mesa, S. Nam, H. Yu, and R. Jove. 2007. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity. Mol. Cancer Res. 5: 823-832. (Pubitemid 47294810)
46. Lewis, H. D., A. Winter, T. F. Murphy, S. Tripathi, V. N. Pandey, and B. E. Barton. 2008. STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides: differential activity between 5′ and 3′ ends. Mol. Cancer Ther. 7: 1543-1550.
47. Lombardi, M. S., A. Kavelaars, M. Schedlowski, J. W. Bijlsma, K. L. Okihara, M. Van de Pol, S. Ochsmann, C. Pawlak, R. E. Schmidt, and C. J. Heijnen. 1999. Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J. 13: 715-725. (Pubitemid 29156403)
48. Vroon, A., A. Kavelaars, V. Limmroth, M. S. Lombardi, M. U. Goebel, A. M. Van Dam, M. G. Caron, M. Schedlowski, and C. J. Heijnen. 2005. G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Immunol. 174: 4400-4406. (Pubitemid 40396023)
49. Vroon, A., M. S. Lombardi, A. Kavelaars, and C. J. Heijnen. 2003. Changes in the G-protein-coupled receptor desensitization machinery during relapsing-rogressive experimental allergic encephalomyelitis. J. Neuroimmunol. 137: 79-86. (Pubitemid 36351568)
50. Lombardi, M. S., A. Kavelaars, P. Penela, E. J. Scholtens, M. Roccio, R. E. Schmidt, M. Schedlowski, F. Mayor, Jr., and C. J. Heijnen. 2002. Oxidative stress decreases G protein-coupled receptor kinase 2 in lymphocytes via a calpain-dependent mechanism. Mol. Pharmacol. 62: 379-388. (Pubitemid 34804118)
51. Lappano, R., and M. Maggiolini. 2011. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat. Rev. Drug Discov. 10: 47-60.
52. Robas, N., M. O'Reilly, S. Katugampola, and M. Fidock. 2003. Maximizing serendipity: strategies for identifying ligands for orphan G-protein-coupled receptors. Curr. Opin. Pharmacol. 3: 121-126. (Pubitemid 36411234)
53. Li, T. K., and B. S. Fox. 1993. Effect of prostaglandin E2 (PGE2) on IL-3/ granulocyte-macrophage colony-stimulating factor production by T helper cells. Mode of stimulation and presence of costimulation can determine response to PGE2. J. Immunol. 150: 1680-1690.
54. Holla, V. R., D. Wang, J. R. Brown, J. R. Mann, S. Katkuri, and R. N. DuBois. 2005. Prostaglandin E2 regulates the complement inhibitor CD55/decay-accelerating factor in colorectal cancer. J. Biol. Chem. 280: 476-483. (Pubitemid 40165012)
55. Vaknin-Dembinsky, A., G. Murugaiyan, D. A. Hafler, A. L. Astier, and H. L. Weiner. 2008. Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis. J. Neuroimmunol. 195: 140-145.
56. Sansom, D. M., and L. S. Walker. 2006. The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol. Rev. 212: 131-148. (Pubitemid 44116705)
57. Martín, P., M. Gómez, A. Lamana, A. Cruz-Adalia,M. Ramírez-Huesca,M. A. Ursa, M. Yáñez-Mo, and F. Sánchez-Madrid. 2010. CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation. Mol. Cell. Biol. 30: 4877-4889.
58. Nataraj, C., D. W. Thomas, S. L. Tilley, M. T. Nguyen, R. Mannon, B. H. Koller, and T. M. Coffman. 2001. Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J. Clin. Invest. 108: 1229-1235. (Pubitemid 32995382)
59. Fujino, H., W. Xu, and J. W. Regan. 2003. Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J. Biol. Chem. 278: 12151-12156. (Pubitemid 36800194)
60. De Jager, P. L., X. Jia, J. Wang, P. I. de Bakker, L. Ottoboni, N. T. Aggarwal, L. Piccio, S. Raychaudhuri, D. Tran, C. Aubin, et al; International MS Genetics Consortium. 2009. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 41: 776-782.
61. Aussel, C., D. Mary, and M. Fehlmann. 1987. Prostaglandin synthesis in human T cells: its partial inhibition by lectins and anti-CD3 antibodies as a possible step in T cell activation. J. Immunol. 138: 3094-3099. (Pubitemid 17071876)
62. Mahic, M., S. Yaqub, C. C. Johansson, K. Taskén, and E. M. Aandahl. 2006. FOXP3+CD4+CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism. J. Immunol. 177: 246-254. (Pubitemid 43939136)
63. Regan, J.W. 2003. EP2 and EP4 prostanoid receptor signaling. Life Sci. 74: 143-153.